NASDAQ:XERS | Cash Flow Statement | Xeris Biopharma Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$31.1M
2026-03-31$2.23M$337,000.00$9.87M-$325,000.00-$8.84M
2025-12-31$11.08M$335,000.00$20.04M-$333,000.00-$266,000.00
2025-09-30$621,000.00
2025-06-30-$1.93M
2025-03-31-$9.22M$315,000.00-$10.03M-$13,000.00-$3.14M
2024-12-31-$5.11M$313,000.00$1.98M$10.02M$398,000.00
2024-09-30-$15.74M
2024-06-30-$15.01M
2024-03-31-$18.98M$326,000.00-$20.3M-$19.65M$35.19M
2023-12-31-$13.39M$346,000.00$7.47M$14.87M-$1.23M
2023-09-30-$12.19M
2023-06-30-$19.84M
2023-03-31-$16.83M$364,000.00-$26.14M-$43.98M-$863,000.00
2022-12-31-$12.93M$366,000.00-$16.12M$9.17M$49.16M
2022-09-30-$21.83M
2022-06-30-$26.19M
2022-03-31-$33.71M$321,000.00-$48.41M$6.72M$78.19M
2021-12-31-$50.79M$349,000.00-$28.95M$131,000.00$36.6M$125,000.00
2021-09-30-$26.01M
2021-06-30-$27.52M
2021-03-31-$18.41M$337,000.00-$23.96M$26.3M$26.66M
2020-12-31-$21.86M$446,000.00-$10.87M$225,000.00$7.25M$3.33M
2020-09-30-$16M
2020-06-30-$24.1M
2020-03-31-$29.18M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$554,000.00$1.31M$28.63M-$696,000.00$11.39M
2024-12-31-$54.84M$1.23M-$36.98M$4.88M$36.17M
2023-12-31-$62.26M$1.49M-$47.02M-$6M-$1.61M
2022-12-31-$94.66M$1.4M-$102.89M$34.46M$127.47M
2021-12-31-$122.73M$1.33M-$95.54M$1.09M$97.96M$27.25M
2020-12-31-$91.14M$1.47M-$80.56M$377,000.00-$27.41M$126.06M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.